Trial Profile
A phase IIa study of NH001 in patients with brain injury who are in a vegetative or minimally conscious state.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2016
Price :
$35
*
At a glance
- Drugs Apomorphine (Primary)
- Indications Brain injuries
- Focus Therapeutic Use
- 30 Jan 2016 New trial record